These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 377537)

  • 1. Coagulopathy following peritoneovenous shunting.
    Schwartz ML; Swaim WR; Vogel SB
    Surgery; 1979 Jun; 85(6):671-6. PubMed ID: 377537
    [No Abstract]   [Full Text] [Related]  

  • 2. Coagulopathy following peritoneovenous shunting--an endotoxin medication?
    Fumarola D
    Surgery; 1980 Apr; 87(4):475. PubMed ID: 7368094
    [No Abstract]   [Full Text] [Related]  

  • 3. Disseminated intravascular coagulation with the peritoneovenous shunt.
    Harmon DC; Demirjian Z; Ellman L; Fischer JE
    Ann Intern Med; 1979 May; 90(5):774-6. PubMed ID: 434678
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peritoneovenous shunting in the management of malignant ascites.
    Straus AK; Roseman DL; Shapiro TM
    Arch Surg; 1979 Apr; 114(4):489-91. PubMed ID: 86345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coagulant and procoagulant factors in ascitic fluid--about etiology DIC induced by ascitic fluid infusion (author's transl)].
    Ojiro M
    Igaku Kenkyu; 1981 Oct; 51(4):177-85. PubMed ID: 7331734
    [No Abstract]   [Full Text] [Related]  

  • 6. Intraperitoneal coagulation in chronic liver disease ascites.
    Hoefs J; Barnes T; Halle P
    Dig Dis Sci; 1981 Jun; 26(6):518-22. PubMed ID: 7238271
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peritoneovenous shunting for ascites.
    Wapnick S
    N Engl J Med; 1980 Aug; 303(8):461-2. PubMed ID: 6993947
    [No Abstract]   [Full Text] [Related]  

  • 8. Coagulopathy post peritoneovenous shunt.
    LeVeen HH; Ip M; Ahmed N; Hutto RB; LeVeen EG
    Ann Surg; 1987 Mar; 205(3):305-11. PubMed ID: 3103556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ascites: its correction by peritoneovenous shunting.
    LeVeen HH; Wapnick S; Diaz C; Grosberg S; Kinney M
    Curr Probl Surg; 1979 Feb; 16(2):1-61. PubMed ID: 371915
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current status of the peritoneovenous shunt for the management of intractable ascites.
    Fry PD; Hallgren R; Robertson ME
    Can J Surg; 1979 Nov; 22(6):557-9. PubMed ID: 497929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneovenous shunting for ascites.
    Puig JG; Antón FM; Fernández FA; Aguado AG; Rodriguez JJ
    N Engl J Med; 1980 Aug; 303(8):461. PubMed ID: 7393280
    [No Abstract]   [Full Text] [Related]  

  • 12. The cause of coagulopathy after peritoneovenous shunt for malignant ascites.
    Gleysteen JJ; Hussey CV; Heckman MG
    Arch Surg; 1990 Apr; 125(4):474-7. PubMed ID: 2322114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disseminated intravascular coagulation. Complication of LeVeen peritoneovenous shunts.
    Lerner RG; Nelson JC; Corines P; del Guercio LR
    JAMA; 1978 Nov; 240(19):2064-6. PubMed ID: 702700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of peritoneovenous shunting with the Le Veen valve on ascites, renal function, and coagulation in six patients with intractable ascites.
    Ansley JD; Bethel RA; Bowen PA; Warren WD
    Surgery; 1978 Feb; 83(2):181-7. PubMed ID: 622693
    [No Abstract]   [Full Text] [Related]  

  • 15. Refractory coagulopathy in an infant with loss of clotting proteins into ascitic fluid.
    Johnson CA; Sobrinho TC; Aziz EM; Rogers SB
    Acta Paediatr Scand; 1976 Nov; 65(6):773-5. PubMed ID: 998236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Failure of ascitic fluid replacement for prevention of coagulopathy post peritoneovenous shunt. Case report.
    Gagner M; Franco D
    Acta Chir Scand; 1990 Apr; 156(4):337-40. PubMed ID: 2349854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of coagulopathy after placement of peritoneovenous shunt with replacement of ascitic fluid by normal saline solution.
    Biagini JR; Belghiti J; Fekete F
    Surg Gynecol Obstet; 1986 Oct; 163(4):315-8. PubMed ID: 3764636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Markerfunction of crosslinked fibrin derivatives in ascitic fluid from patients with ovarian cancer: a comparison with ascitic fluid in liver cirrhosis].
    Graeff H; Klaubert W; Klaubert E; Gollwitzer R; von Hugo R; Hafter R
    Geburtshilfe Frauenheilkd; 1983 Jun; 43 Suppl 1():42-6. PubMed ID: 6555132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation disturbances following ascites recirculation.
    Wilde JT; Cooper P; Kennedy HJ; Triger DR; Preston FE
    J Hepatol; 1990 Mar; 10(2):217-22. PubMed ID: 2332593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and comparison of hemocoagulation parameters both in serum and in ascites from patients with gynecologic malignancies.
    Varcaccio-Garofalo G; Selvaggi L; Capozza G; Orlando E; Ferreri R; Restaino A
    Eur J Gynaecol Oncol; 1982; 3(2):113-4. PubMed ID: 7166171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.